DK0470616T3 - Substituerede pyrimidin-derivater, fremgangsmåde til fremstilling og deres anvendelse som reagenser - Google Patents
Substituerede pyrimidin-derivater, fremgangsmåde til fremstilling og deres anvendelse som reagenserInfo
- Publication number
- DK0470616T3 DK0470616T3 DK91113334.6T DK91113334T DK0470616T3 DK 0470616 T3 DK0470616 T3 DK 0470616T3 DK 91113334 T DK91113334 T DK 91113334T DK 0470616 T3 DK0470616 T3 DK 0470616T3
- Authority
- DK
- Denmark
- Prior art keywords
- reagents
- preparation
- pyrimidine derivatives
- substituted pyrimidine
- sorbitol
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract 2
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 239000003288 aldose reductase inhibitor Substances 0.000 abstract 1
- 229940090865 aldose reductase inhibitors used in diabetes Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4025387A DE4025387A1 (de) | 1990-08-10 | 1990-08-10 | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0470616T3 true DK0470616T3 (da) | 1997-08-25 |
Family
ID=6412013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91113334.6T DK0470616T3 (da) | 1990-08-10 | 1991-08-08 | Substituerede pyrimidin-derivater, fremgangsmåde til fremstilling og deres anvendelse som reagenser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5215990A (da) |
| EP (1) | EP0470616B1 (da) |
| JP (1) | JP3094535B2 (da) |
| KR (1) | KR100191385B1 (da) |
| AT (1) | ATE149032T1 (da) |
| AU (1) | AU641797B2 (da) |
| CA (1) | CA2048842C (da) |
| DE (2) | DE4025387A1 (da) |
| DK (1) | DK0470616T3 (da) |
| ES (1) | ES2097774T3 (da) |
| GR (1) | GR3022976T3 (da) |
| IE (1) | IE912828A1 (da) |
| IL (1) | IL99134A (da) |
| NZ (1) | NZ239310A (da) |
| PT (1) | PT98634B (da) |
| ZA (1) | ZA916290B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728704A (en) * | 1992-09-28 | 1998-03-17 | Pfizer Inc. | Substituted pyridmidines for control of diabetic complications |
| PT791355E (pt) | 1996-02-29 | 2002-08-30 | Pfizer | Metodo para diminuir os daos associados com a isquemia nos tecidos |
| JPH09301868A (ja) * | 1996-05-10 | 1997-11-25 | Senju Pharmaceut Co Ltd | 抗白内障剤 |
| DE19710435A1 (de) * | 1997-03-13 | 1998-09-17 | Hoechst Ag | Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen |
| PL350884A1 (en) | 1999-04-01 | 2003-02-10 | Pfizer Prod Inc | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| PT1041068E (pt) | 1999-04-01 | 2004-07-30 | Pfizer Prod Inc | Compostos para o tratamento e prevencao de complicacoes diabeticas |
| EP1247809A3 (en) * | 2001-03-30 | 2003-12-17 | Pfizer Products Inc. | Triazine compounds useful as sorbitol dehydrogenase inhibitors |
| US20040082627A1 (en) * | 2002-06-21 | 2004-04-29 | Darrow James W. | Certain aromatic monocycles as kinase modulators |
| AU2003249369A1 (en) * | 2002-06-21 | 2004-01-06 | Cellular Genomics, Inc. | Certain amino-substituted monocycles as kinase modulators |
| CN1997370B (zh) | 2004-05-19 | 2011-06-01 | 索尔瓦药物有限公司 | N-氨磺酰-n'-芳基哌嗪类化合物在制备用于预防或治疗肥胖和相关疾病的药物中的用途 |
| US20050261292A1 (en) * | 2004-05-19 | 2005-11-24 | Solvay Pharmaceuticals Gmbh | Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions |
| CN115124475B (zh) * | 2022-07-11 | 2023-11-10 | 贵阳学院 | 一种嘧啶衍生物及其制备方法和用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2362276A (en) * | 1942-03-31 | 1944-11-07 | American Cyanamid Co | Beneficiation of acidic minerals |
| US2973362A (en) * | 1959-07-24 | 1961-02-28 | Schorsch Gerald | Method of preparing monosubstituted piperazines |
| US3190883A (en) * | 1962-10-05 | 1965-06-22 | Geschickter Fund Med Res | Aminoalkanol derivatives of piperazines |
| US3296261A (en) * | 1965-03-09 | 1967-01-03 | Bristol Myers Co | 6-hydroxy-pyrimidine-5-acetamides |
| DK8600939A (da) * | 1985-03-05 | 1986-09-06 | ||
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
-
1990
- 1990-08-10 DE DE4025387A patent/DE4025387A1/de not_active Withdrawn
-
1991
- 1991-08-08 DK DK91113334.6T patent/DK0470616T3/da active
- 1991-08-08 NZ NZ239310A patent/NZ239310A/xx unknown
- 1991-08-08 ES ES91113334T patent/ES2097774T3/es not_active Expired - Lifetime
- 1991-08-08 EP EP91113334A patent/EP0470616B1/de not_active Expired - Lifetime
- 1991-08-08 US US07/741,810 patent/US5215990A/en not_active Expired - Lifetime
- 1991-08-08 DE DE59108549T patent/DE59108549D1/de not_active Expired - Lifetime
- 1991-08-08 IL IL9913491A patent/IL99134A/en not_active IP Right Cessation
- 1991-08-08 AT AT91113334T patent/ATE149032T1/de not_active IP Right Cessation
- 1991-08-09 CA CA002048842A patent/CA2048842C/en not_active Expired - Lifetime
- 1991-08-09 PT PT98634A patent/PT98634B/pt active IP Right Grant
- 1991-08-09 KR KR1019910013759A patent/KR100191385B1/ko not_active Expired - Fee Related
- 1991-08-09 ZA ZA916290A patent/ZA916290B/xx unknown
- 1991-08-09 IE IE282891A patent/IE912828A1/en not_active IP Right Cessation
- 1991-08-09 AU AU82561/91A patent/AU641797B2/en not_active Ceased
- 1991-08-09 JP JP03223671A patent/JP3094535B2/ja not_active Expired - Lifetime
-
1997
- 1997-03-31 GR GR970400652T patent/GR3022976T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0470616A3 (en) | 1992-03-25 |
| JP3094535B2 (ja) | 2000-10-03 |
| KR100191385B1 (ko) | 1999-06-15 |
| ES2097774T3 (es) | 1997-04-16 |
| EP0470616B1 (de) | 1997-02-19 |
| IL99134A (en) | 1995-08-31 |
| ZA916290B (en) | 1992-04-29 |
| KR920004381A (ko) | 1992-03-27 |
| CA2048842A1 (en) | 1992-02-11 |
| US5215990A (en) | 1993-06-01 |
| IL99134A0 (en) | 1992-07-15 |
| NZ239310A (en) | 1993-07-27 |
| ATE149032T1 (de) | 1997-03-15 |
| AU641797B2 (en) | 1993-09-30 |
| JPH04230669A (ja) | 1992-08-19 |
| GR3022976T3 (en) | 1997-06-30 |
| PT98634B (pt) | 1999-01-29 |
| EP0470616A2 (de) | 1992-02-12 |
| PT98634A (pt) | 1993-09-30 |
| IE912828A1 (en) | 1992-02-12 |
| DE4025387A1 (de) | 1992-02-13 |
| AU8256191A (en) | 1992-02-13 |
| CA2048842C (en) | 2002-04-09 |
| DE59108549D1 (de) | 1997-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO900822D0 (no) | Substituerte pyrimidinderivater, deres fremstilling og anvendelse. | |
| DK0470616T3 (da) | Substituerede pyrimidin-derivater, fremgangsmåde til fremstilling og deres anvendelse som reagenser | |
| NO982606D0 (no) | Naftylsubstituerte benzimidazolderivater som antikoagulanter | |
| DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
| TR199600474A2 (tr) | Heterosiklik halka-füzyonlu pirimidin türevleri. | |
| NO953975L (no) | Monoklonale antistoffer, haptener, immunogene konjugater, fremgangsmåte for deres fremstilling og kit for anvendelse derav | |
| NO20020759L (no) | N<o>6</o> heterocykliske substituerte adenosinderivater | |
| NO20022532L (no) | Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser | |
| DK0839041T3 (da) | Salte af amidinderivater og cyclooxygenaseinhibitorer, deres fremstillingsmåde og anvendelse som medikamenter og farmaceutiske sammensætninger indeholdende disse | |
| NO890893D0 (no) | 6-substituerte purinylpiperazinderivater og fremgangsmaate for deres fremstilling. | |
| DK0489836T3 (da) | Lysaktiverede acyl-enzymer | |
| FR2590255B1 (fr) | Procede de preparation de derives de la pteridine | |
| EA199900655A1 (ru) | Композиция на основе пароксетина | |
| DK192890A (da) | 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme | |
| DE60217572D1 (de) | System und Verfahren zum zeitschlitzbasierten Erlernen und Durchsuchen von ARL Tabellen unter verwendung von Schreib-snoop | |
| DK0557211T3 (da) | Kondensationsprodukter og deres anvendelse som plastificeringsmidler | |
| TH5731A (th) | การหาและการควบคุมแบคทีเรียประเภทซัลเฟตรีดัคชัน |